Suppr超能文献

穹窿体多聚(ADP - 核糖)聚合酶与哺乳动物端粒酶相关,并且在体内对于端粒酶功能和穹窿体结构而言是可有可无的。

Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo.

作者信息

Liu Yie, Snow Bryan E, Kickhoefer Valerie A, Erdmann Natalie, Zhou Wen, Wakeham Andrew, Gomez Marla, Rome Leonard H, Harrington Lea

机构信息

Ontario Cancer Institute/Advanced Medical Discovery Institute, Toronto, Ontario M5G 2C1, Canada.

出版信息

Mol Cell Biol. 2004 Jun;24(12):5314-23. doi: 10.1128/MCB.24.12.5314-5323.2004.

Abstract

Vault poly(ADP-ribose) polymerase (VPARP) was originally identified as a minor protein component of the vault ribonucleoprotein particle, which may be involved in molecular assembly or subcellular transport. In addition to the association of VPARP with the cytoplasmic vault particle, subpopulations of VPARP localize to the nucleus and the mitotic spindle, indicating that VPARP may have other cellular functions. We found that VPARP was associated with telomerase activity and interacted with exogenously expressed telomerase-associated protein 1 (TEP1) in human cells. To study the possible role of VPARP in telomerase and vault complexes in vivo, mVparp-deficient mice were generated. Mice deficient in mVparp were viable and fertile for up to five generations, with no apparent changes in telomerase activity or telomere length. Vaults purified from mVparp-deficient mouse liver appeared intact, and no defect in association with other vault components was observed. Mice deficient in mTep1, whose disruption alone does not affect telomere function but does affect the stability of vault RNA, showed no additional telomerase or telomere-related phenotypes when the mTep1 deficiency was combined with an mVparp deficiency. These data suggest that murine mTep1 and mVparp, alone or in combination, are dispensable for normal development, telomerase catalysis, telomere length maintenance, and vault structure in vivo.

摘要

穹窿体多聚(ADP - 核糖)聚合酶(VPARP)最初被鉴定为穹窿核糖核蛋白颗粒的一种次要蛋白质成分,它可能参与分子组装或亚细胞运输。除了VPARP与细胞质穹窿体颗粒的关联外,VPARP的亚群定位于细胞核和有丝分裂纺锤体,这表明VPARP可能具有其他细胞功能。我们发现VPARP与人细胞中的端粒酶活性相关,并与外源性表达的端粒酶相关蛋白1(TEP1)相互作用。为了研究VPARP在体内端粒酶和穹窿体复合物中的可能作用,我们构建了mVparp基因缺陷型小鼠。mVparp基因缺陷的小鼠能够存活并繁殖多达五代,端粒酶活性或端粒长度没有明显变化。从mVparp基因缺陷的小鼠肝脏中纯化的穹窿体看起来完整,并且未观察到与其他穹窿体成分结合存在缺陷。单独缺失mTep1不会影响端粒功能,但会影响穹窿体RNA的稳定性,当mTep1缺陷与mVparp缺陷同时存在时,mTep1缺陷型小鼠没有表现出额外的端粒酶或端粒相关表型。这些数据表明,小鼠的mTep1和mVparp单独或联合起来,对于体内正常发育、端粒酶催化、端粒长度维持和穹窿体结构都是可有可无的。

相似文献

5
The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
J Cell Sci. 2003 Nov 1;116(Pt 21):4391-400. doi: 10.1242/jcs.00749. Epub 2003 Sep 16.
6
Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
Biochem Biophys Res Commun. 2005 Jan 7;326(1):100-7. doi: 10.1016/j.bbrc.2004.11.006.
7
Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo.
Mol Cell Biol. 2000 Nov;20(21):8178-84. doi: 10.1128/MCB.20.21.8178-8184.2000.
8
The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase.
J Cell Biol. 1999 Sep 6;146(5):917-28. doi: 10.1083/jcb.146.5.917.
9
Structure, Dynamics and Functional Implications of the Eukaryotic Vault Complex.
Subcell Biochem. 2024;104:531-548. doi: 10.1007/978-3-031-58843-3_20.
10
Structural domains of vault proteins: a role for the coiled coil domain in vault assembly.
Biochem Biophys Res Commun. 2002 Mar 1;291(3):535-41. doi: 10.1006/bbrc.2002.6472.

引用本文的文献

1
The small noncoding RNA is dispensable to mouse development.
RNA. 2024 Oct 16;30(11):1465-1476. doi: 10.1261/rna.080161.124.
2
PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression.
Genome Med. 2024 Jul 22;16(1):91. doi: 10.1186/s13073-024-01328-1.
3
Structure, Dynamics and Functional Implications of the Eukaryotic Vault Complex.
Subcell Biochem. 2024;104:531-548. doi: 10.1007/978-3-031-58843-3_20.
5
The small non-coding RNA is dispensable to mouse development.
bioRxiv. 2024 Jun 5:2024.06.01.596958. doi: 10.1101/2024.06.01.596958.
6
Functional roles of ADP-ribosylation writers, readers and erasers.
Front Cell Dev Biol. 2022 Aug 11;10:941356. doi: 10.3389/fcell.2022.941356. eCollection 2022.
7
The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks.
Cancers (Basel). 2021 Apr 23;13(9):2042. doi: 10.3390/cancers13092042.
9
Modification of , , and Gene Polymorphisms on the Relation between Bisphenol A Exposure and Liver Abnormality.
Int J Environ Res Public Health. 2020 Apr 17;17(8):2794. doi: 10.3390/ijerph17082794.
10
Assessment of PARP4 as a candidate breast cancer susceptibility gene.
Breast Cancer Res Treat. 2019 Aug;177(1):145-153. doi: 10.1007/s10549-019-05286-w. Epub 2019 May 22.

本文引用的文献

1
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice.
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6080-5. doi: 10.1073/pnas.0401580101. Epub 2004 Apr 12.
3
Protecting the terminus: t-loops and telomere end-binding proteins.
Cell Mol Life Sci. 2003 Nov;60(11):2283-94. doi: 10.1007/s00018-003-3244-z.
4
Vaults: a ribonucleoprotein particle involved in drug resistance?
Oncogene. 2003 Oct 20;22(47):7458-67. doi: 10.1038/sj.onc.1206947.
5
The vault complex.
Cell Mol Life Sci. 2003 Sep;60(9):1828-37. doi: 10.1007/s00018-003-3030-y.
6
PARP goes transcription.
Cell. 2003 Jun 13;113(6):677-83. doi: 10.1016/s0092-8674(03)00433-1.
7
Evolving views of telomerase and cancer.
Trends Cell Biol. 2003 Jun;13(6):289-94. doi: 10.1016/s0962-8924(03)00085-0.
8
TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres.
Genes Dev. 2003 Jun 1;17(11):1328-33. doi: 10.1101/gad.1077103.
9
Telomere repeat binding factors: keeping the ends in check.
Cancer Lett. 2003 May 15;194(2):189-97. doi: 10.1016/s0304-3835(02)00706-1.
10
Biochemical aspects of telomerase function.
Cancer Lett. 2003 May 15;194(2):139-54. doi: 10.1016/s0304-3835(02)00701-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验